Impact of the preprocedural frequency of paroxysmal atrial fibrillation on the clinical outcome after catheter ablation

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 10, 2012, Pages 1236-1241

  Miyazaki, Shinsuke ^a   Kuwahara, Taishi ^a   Takahashi, Atsushi ^a  

^a YOKOSUKA KYOSAI HOSPITAL   (Japan)

Author keywords

atrial fibrillation; catheter ablation; frequency; pulmonary vein isolation

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CATHETER ABLATION; DISEASE DURATION; FEMALE; GENDER; HEART ATRIUM; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SIZE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PROGNOSIS; PULMONARY VEIN ISOLATION;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULMONARY VEINS; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84867102768     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03487.x     Document Type: Article

References (29)

1. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, et al,. Spontaneous initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. N Engl J Med 1998; 339: 659-666.
2. Chen SA, Hsieh M, Tai C, Tsai C, Prakash VS, Yu W, Hsu T, et al,. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100: 1879-1886.
3. Haïssaguerre M, Shah DC, Jaïs P, Hocini M, Yamane T, Deisenhofer I, Chauvin M, et al,. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: 2463-2465.
4. Takahashi A, Iesaka Y, Takahashi Y, Takahashi R, Kobayashi K, Takagi K, Kuboyama O, et al,. Electrical connections between pulmonary veins: Implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation. Circulation 2002; 105: 2998-3003.
5. Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jais P, Hocini M, et al,. Drug vs. ablation for the treatment of atrial fibrillation: The evidence supporting catheter ablation. Eur Heart J 2010; 31: 1046-1054.
6. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, Lellouche N, et al,. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
7. Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, Minners J, et al,. Small and large isolation areas around the pulmonary veins for treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 2007; 115: 3057-3063.
8. Liu X, Dong J, Mavrakis HE, Hu F, Long D, Fang D, Yu R, et al,. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: A randomized comparison between two different isolation approaches. J Cardiovasc Electrophysiol 2006; 17: 1263-1270.
9. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, et al,; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 2012; 9: 632-696.e21.
10. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, et al,. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
11. Aboaf AP, Wolff PS,. Paroxysmal atrial fibrillation: A common but neglected entity. Arch Intern Med 1996; 156: 362-367.
12. Sakamoto H, Kurabayashi M, Nagai R, Fujii J,. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation. Circulation 1998; 98: 1045-1056.
13. Kerr CR, Humphries KH, Talajic M, Klein G, Connolly SJ, Green M, Boone J, et al,. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian registry of atrial fibrillation. Am Heart J 2005; 149: 489-496.
14. Kuwahara T, Takahashi A, Kobori A, Miyazaki S, Takahashi Y, Takei A, Nozato T, et al,. Safe and effective ablation of atrial fibrillation: Importance of esophageal temperature monitoring to avoid periesophageal nerve injury as a complication of pulmonary vein isolation. J Cardiovasc Electrophysiol 2009; 20: 1-6.
15. Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, Isobe M, et al,. Catheter ablation of atrial fibrillation in patients with valvular heart disease: Long-term follow-up results. J Cardiovasc Electrophysiol 2010: 21: 1193-1198.
16. Arentz T, Macle L, Kalusche D, Hocini M, Jais P, Shah D, Haissaguerre M,. "Dormant" pulmonary vein conduction revealed by adenosine alter ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004; 15: 1041-1047.
17. Hachiya H, Hirao K, Takahashi A, Nagata Y, Suzuki K, Maeda S, Sasaki T, et al,. Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation. J Cardiovasc Electrophysiol 2007; 1-7.
18. Kumagai K, Naito S, Nakamura K, Hayashi T, Fukazawa R, Sato C, Takemura N, et al,. ATP-induced dormant pulmonary veins originating from the carina region after circumferential pulmonary vein isolation of atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 494-500.
19. Shah D, Haissaguerre M, Takahashi A, Jais P, Clementy J,. Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation 2000; 102: 1517-1522.
20. Shah D, Haissaguerre M, Jais P, Takahashi A, Hocini M, Clementy J,. High-density mapping of activation through an incomplete isthmus ablation line. Circulation 1999; 19: 211-215.
21. Shah D, Dumonceau JM, Burri H, Sunthorn H, Schroft A, Gentil-Baron P, Yokoyama Y, et al,. Acute pyloric spasm and gastric hypomotility: An extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol 2005; 46: 327-330.
22. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, Dimitri H, et al,. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: Characterizing the "second factor." J Am Coll Cardiol 2009; 53: 1182-1191.
23. Haïssaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, Rostock T, et al,. Catheter ablation of long-lasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005; 16: 1138-1147.
24. Wright M, Haissaguerre M, Knecht S, Matsuo S, O'neill M, Nault I, Lellouche N, et al,. State of the art: Catheter ablation of atrial firbrillation. J Cardiovasc Electrophysiol 2008; 19: 583-592.
25. Rostock T, Steven D, Hoffmann B, Servatius H, Drewitz I, Sydow K, Müllerleile K, et al,. Chronic atrial fibrillation is a biatrial arrhythmia: Data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach. Circ Arrhythm Electrophysiol 2008; 1: 344-353.
26. Hocini M, Nault I, Wright M, Veenhuyzen G, Narayan SM, Jaïs P, Lim KT, et al,. Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol. 2010 9; 55: 1007-1016.
27. Sanders P, Berenfeld O, Hocini M, Jaïs P, Vaidyanathan R, Hsu LF, Garrigue S, et al,. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005; 112: 789-797.
28. Sanders P, Nalliah CJ, Dubois R, Takahashi Y, Hocini M, Rotter M, Rostock T, et al,. Frequency mapping of the pulmonary veins in paroxysmal versus permanent atrial fibrillation. J Cardiovasc Electrophysiol 2006; 17: 965-972.
29. Shah D, Sunthorn, H, Burri H, Gentil-Baron P,. Evaluation of an individualized strategy of cavotricuspid isthmus ablation as an adjunct to atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007; 18: 926-930.